Specialty Pharmacy

Novel HIV treatment protected immune cells against HIV for nearly a month.

More than one-third of HIV-positive patients are not vaccinated against hepatitis B virus.

FDA grants priority approval to arsenic trioxide (Trisenox) plus tretinoin for leukemia treatment.

Afatinib (Gilotrif) found to improve overall survival among patients with EGFR-mutated non-small cell lung cancer.

Top news of the day from across the health care landscape.

Automated HCV antigen testing has a much faster turnaround time and lower costs.

Important considerations for pharmacists to concerning the switch from a brand name biologic to a new biosimilar.

An investigational immunotherapy for multiple sclerosis targets Epstein-Barr virus.

The Maraba virus combined with an immune checkpoint inhibitor increased triple-negative breast cancer survival in mice.

Certain hormonal forms of birth control could place women at a higher risk of contracting HIV.

Health care organizations show support for proposed Medicare Part D rules that require direct and indirect remuneration fees to be included at the point-of-sale.

Top news of the day from across the health care landscape.

Thus far there is no intervention that clearly reduces the risk of HCV infection from a mother to her child.

Olaparib (Lynparza) is indicated to treat HER2-negative metastatic breast cancer with BRCA mutations.

John Giannouris, vice president, Specialty Pharmacy Services, ValueCentric, speaks about data analytics and specialty pharmacy.

Myeloablative autologous hematopoietic stem cell transplant may provide long-term benefits for patients with scleroderma.

A high concentration of Americans with hepatitis C virus are incarcerated.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.

ART was associated with lower rates of high-risk human papillomavirus and invasive cervical cancer among women with HIV.

Show us how you are celebrating National Pharmacist Day by using #APharmacistIs on social media.

Investigational immunotherapy combination may benefit patients with unresectable kidney cancer.

Denosumab (Xgeva) demonstrated non-inferiority to zoledronic acid in patients with multiple myeloma.

Advancing biomarker research may help determine which patients with non-invasive breast cancer will develop invasive disease.

Novel gene therapy technique may lead to a long-term therapy against HIV.

Top news of the day from across the health care landscape.

Ribavirin steady-state serum levels correspond to high rates of efficacy and low adverse effect from direct-acting antiviral drugs for difficult-to-treat hepatitis C virus.